Treatment With Voclosporin and Anifrolumab in a Patient With Lupus Nephritis and Refractory Discoid Lupus Erythematosus: A Case Report and Literature Review

被引:1
|
作者
Karagenova, Ralina [1 ]
Vodusek, Ziga [2 ]
Krimins, Rebecca [3 ]
Krieger, Adam [2 ]
Timlin, Homa [2 ]
机构
[1] Univ Hawaii, John A Burns Sch Med, Rheumatol, Honolulu, HI USA
[2] Johns Hopkins Univ, Sch Med, Rheumatol, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Sch Med, Radiol & Radiol Sci, Baltimore, MD USA
关键词
systemic lupus erythematosus; sle; anifrolumab; voclosporin; sle and lupus nephritis; lupus nephritis; discoid lupus erythematosus (dle); MORTALITY;
D O I
10.7759/cureus.55321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) is a complex heterogeneous disease with multiple clinical manifestations. Recently, two medications, anifrolumab and voclosporin, have been approved for the treatment of adults with SLE and lupus nephritis (LN), respectively. We present the case of an elderly woman with LN and refractory discoid lupus erythematosus (DLE), who was treated successfully with a combination of voclosporin and anifrolumab without major infections.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Treatment of discoid lupus with lenalidomide and anifrolumab: Case report and review of the literature
    Centner, Connor S.
    Robertson, Nicole M.
    Kang, Jun
    Sander, Inbal B.
    Timlin, Homa
    LUPUS, 2024, 33 (13) : 1487 - 1491
  • [2] Treatment With Anifrolumab for Discoid Lupus Erythematosus
    Trentin, Francesca
    Tani, Chiara
    Elefante, Elena
    Stagnaro, Chiara
    Zucchi, Dina
    Mosca, Marta
    JAMA DERMATOLOGY, 2023, 159 (02) : 224 - 226
  • [3] Anifrolumab in Two Elderly Patients with Refractory Discoid Lupus Erythematosus
    Karagenova, R.
    Timlin, H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S184 - S184
  • [4] Impressive resolution of refractory hypertrophic discoid lupus erythematosus with anifrolumab
    Ocon, Anthony
    Sugastti, Eduardo Avalos
    Duffy, Nananamibia
    BMJ CASE REPORTS, 2024, 17 (06)
  • [5] Anifrolumab for Adolescent Discoid Lupus Erythematosus
    Shaw, Katharina S.
    Rajeh, Ahmad
    Le, Todd
    Kahn, Philip J.
    Oza, Vikash S.
    Arkin, Lisa M.
    Vleugels, Ruth Ann
    JAMA NETWORK OPEN, 2023, 6 (10) : E2338200
  • [6] Disseminated Hypertrophic Discoid Lupus Erythematosus in a Patient with Vitiligo: A Case Report and Literature Review
    Zhu, Qing
    He, Yijia
    Chen, Sijia
    Zhang, Guoqiang
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2024, 17 : 1519 - 1526
  • [7] Assessment of Clinical Response to Anifrolumab in Patients With Refractory Discoid Lupus Erythematosus
    Shaw, Katharina
    Sanchez-Melendez, Stephanie
    Taylor, Dustin
    Barker, Julia
    LaChance, Avery
    Shahriari, Neda
    Vleugels, Ruth Ann
    JAMA DERMATOLOGY, 2023, 159 (05) : 560 - 563
  • [8] Anifrolumab for treatment of refractory cutaneous lupus erythematosus
    Blum, Franklin R.
    Sampath, Ashwath J.
    Foulke, Galen T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (11) : 1998 - 2001
  • [9] Role of Anifrolumab in Refractory Cutaneous Manifestations of Lupus Erythematosus: A Case Series and Literature Review
    Khan, Muhammad Atif
    Khan, Faiza Humayun
    Khan, Hina Benish
    Saadeh, Constantine
    Davey, Nichole
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (05)
  • [10] Improvement in mucosal discoid lupus erythematosus with anifrolumab
    Shaw, Katharina
    Taylor, Dustin
    Sanchez-Melendez, Stephanie
    Barker, Julia
    Lonowski, Sarah
    Shahriari, Neda
    Porter, Hannah J.
    Morley, Keith
    LaChance, Avery
    Vleugels, Ruth Ann
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (10) : 1165 - 1167